overall survival

News

Acalabrutinib Improves PFS and OS Over Other First-Line Regimens in CLL

02/16/2021

Journal of Clinical Pathways

Research Reports

Treatment Pathways for First-Line Metastatic Non-Small Cell Lung Cancer: Cost and Survival

10/21/2020

Lalan Wilfong, MD

Aimee Ginsburg, PharmD, BCPS

J Russell Hoverman, MD, PhD

John M Burke, MD

Leslie T Busby, MD

Angela Hsieh, PharmD, BCOP

Kartik Konduri, MD

Marcus A Neubauer, MD

Abstract: Value Pathways powered by NCCN™ provides oncologists with a list of clinically proven treatment options that support the delivery of high-quality, cost-effective cancer care. We evaluated the economic and...

...

10/21/2020

Journal of Clinical Pathways

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

September 21 ⁠–⁠ September 22

September 30 ⁠–⁠ October 2

October 1 ⁠–⁠ October 2

October 2 ⁠–⁠ October 5

October 5 ⁠–⁠ October 6

October 14 ⁠–⁠ October 16

October 16 ⁠–⁠ October 19

October 19 ⁠–⁠ October 20

October 26 ⁠–⁠ October 27

October 29 ⁠–⁠ November 2

See Full Calendar

overall survival

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products